The Rheumatologist
COVID-19 News
  • Connect with us:
  • Facebook
  • Twitter
  • LinkedIn
  • YouTube
  • Feed
  • Home
  • Conditions
    • Rheumatoid Arthritis
    • SLE (Lupus)
    • Crystal Arthritis
      • Gout Resource Center
    • Spondyloarthritis
    • Osteoarthritis
    • Soft Tissue Pain
    • Scleroderma
    • Vasculitis
    • Systemic Inflammatory Syndromes
    • Guidelines
  • Resource Centers
    • Ankylosing Spondylitis Resource Center
    • Gout Resource Center
    • Rheumatoid Arthritis Resource Center
    • Systemic Lupus Erythematosus Resource Center
  • Drug Updates
    • Biologics & Biosimilars
    • DMARDs & Immunosuppressives
    • Topical Drugs
    • Analgesics
    • Safety
    • Pharma Co. News
  • Professional Topics
    • Ethics
    • Legal
    • Legislation & Advocacy
    • Career Development
      • Certification
      • Education & Training
    • Awards
    • Profiles
    • President’s Perspective
    • Rheuminations
  • Practice Management
    • Billing/Coding
    • Quality Assurance/Improvement
    • Workforce
    • Facility
    • Patient Perspective
    • Electronic Health Records
    • Apps
    • Information Technology
    • From the College
    • Multimedia
      • Audio
      • Video
  • Resources
    • Issue Archives
    • ACR Convergence
      • Systemic Lupus Erythematosus Resource Center
      • Rheumatoid Arthritis Resource Center
      • Gout Resource Center
      • Abstracts
      • Meeting Reports
      • ACR Convergence Home
    • American College of Rheumatology
    • ACR ExamRheum
    • Research Reviews
    • ACR Journals
      • Arthritis & Rheumatology
      • Arthritis Care & Research
      • ACR Open Rheumatology
    • Rheumatology Image Library
    • Treatment Guidelines
    • Rheumatology Research Foundation
    • Events
  • About Us
    • Mission/Vision
    • Meet the Authors
    • Meet the Editors
    • Contribute to The Rheumatologist
    • Subscription
    • Contact
  • Advertise
  • Search
You are here: Home / Articles / Rheumatology Research Foundation Launches $75M Fundraising Push

Rheumatology Research Foundation Launches $75M Fundraising Push

November 19, 2018 • By From the College

  • Tweet
  • Email
Print-Friendly Version / Save PDF
Sinart Creative / shutterstock.com

Sinart Creative / shutterstock.com

The Rheumatology Research Foundation has embarked on its third and most ambitious fundraising campaign, with a goal of raising $75 million. The Leading Boldly: Transforming Rheumatology campaign will support Foundation programs to recruit the best and brightest into the field, train rheumatology health professionals at all career stages and support investigators conducting research that will lead us to more options for people with rheumatic disease.

You Might Also Like
  • Rheumatology Research Foundation Fundraising Campaign Exceeds $60M Goal
  • Rheumatology Research Foundation’s Partnership with CRT Allows for Investment in Research, Training
  • Rheumatology Research Foundation Launches Honorary Board of Advisors
Explore This Issue
November 2018
Also By This Author
  • Year in Review: The ACR/ARHP/RheumPAC’s Advocacy Efforts in 2017

In conjunction with the ACR/ARHP Annual Meeting in Chicago last month, supporters of the Foundation were celebrated at the Donors of Merit recognition event. This annual event honors those who contributed to the Foundation throughout the year.

ad goes here:advert-1
ADVERTISEMENT
SCROLL TO CONTINUE

Foundation President Abby G. Abelson, MD, applauded leaders who have played an essential role in the Foundation’s success. Members of the Corporate Roundtable, Pinnacle Society, Cornerstone Society, Founders Circle and Champion Circle were among those acknowledged for their extraordinary dedication. “Their commitment to the specialty has resulted in significant advancements for rheumatology research and education initiatives.”

Planning for the Leading Boldly campaign started early last year as the Foundation identified campaign leaders already receiving philanthropic support from several Corporate Roundtable members. AbbVie, Amgen, and Pfizer are among the pharmaceutical industry leaders who have joined the dynamic partnership in support of Leading Boldly.

ad goes here:advert-2
ADVERTISEMENT
SCROLL TO CONTINUE

“AbbVie’s continued support of the Rheumatology Research Foundation represents our shared goal to make a remarkable impact on the lives of patients with rheumatic diseases,” said Jim Salanty, vice president, U.S. Rheumatology, AbbVie. “We are honored to be a partner of the Leading Boldly campaign support of innovative research and training opportunities to help revolutionize care in the field of rheumatology.”

Amgen Inc. is also an integral supporter of the Foundation’s awards and grants program. “As a long-time partner of the Rheumatology Research Foundation, we are thrilled to support the new campaign and continue to help drive advancements that positively affect patient outcomes,” says Helen Jordan, vice president and general manager, Inflammation and Nephrology, Amgen.

Through partnerships and collaborations with other healthcare leaders, the Foundation is working to transform rheumatology by advancing solutions that foster the continued development of new treatments and therapies, cultivating future generations of rheumatology professionals, and providing patients with access to the most innovative treatments.

ad goes here:advert-3
ADVERTISEMENT
SCROLL TO CONTINUE

For more information about Foundation programs supported by the Leading Boldly: Transforming Rheumatology campaign, visit www.rheumresearch.org.

Filed Under: From the College Tagged With: campaign, Fundraising, Rheumatology Research FoundationIssue: November 2018

You Might Also Like:
  • Rheumatology Research Foundation Fundraising Campaign Exceeds $60M Goal
  • Rheumatology Research Foundation’s Partnership with CRT Allows for Investment in Research, Training
  • Rheumatology Research Foundation Launches Honorary Board of Advisors
  • Rheumatology Research Foundation’s Campaign to Advance Patient Care Ahead of Schedule

Rheumatology Research Foundation

The Foundation is the largest private funding source for rheumatology research and training in the U.S.

Learn more »

ACR Convergence

Don’t miss rheumatology’s premier scientific meeting for anyone involved in research or the delivery of rheumatologic care or services.

Visit the ACR Convergence site »

Meeting Abstracts

Browse and search abstracts from the ACR Convergence and ACR/ARP Annual Meetings going back to 2012.

Visit the Abstracts site »

The Rheumatologist newsmagazine reports on issues and trends in the management and treatment of rheumatic diseases. The Rheumatologist reaches 11,500 rheumatologists, internists, orthopedic surgeons, nurse practitioners, physician assistants, nurses, and other healthcare professionals who practice, research, or teach in the field of rheumatology.

About Us / Contact Us / Advertise / Privacy Policy / Terms of Use

  • Connect with us:
  • Facebook
  • Twitter
  • LinkedIn
  • YouTube
  • Feed

Copyright © 2006–2021 American College of Rheumatology. All rights reserved.

ISSN 1931-3268 (print)
ISSN 1931-3209 (online)

loading Cancel
Post was not sent - check your email addresses!
Email check failed, please try again
Sorry, your blog cannot share posts by email.
This site uses cookies: Find out more.